Literature DB >> 20303507

Anticoagulation management during cardiopulmonary bypass: a survey of 54 North American institutions.

Robert L Lobato1, George J Despotis, Jerrold H Levy, Linda J Shore-Lesserson, Melvin O Carlson, Elliott Bennett-Guerrero.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20303507     DOI： 10.1016/j.jtcvs.2010.02.038

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  10 in total

1.  Method to calculate the protamine dose necessary for reversal of heparin as a function of activated clotting time in patients undergoing cardiac surgery.

Authors:  Javier Suárez Cuenca; Pilar Gayoso Diz; Francisco Gude Sampedro; J Marcos Gómez Zincke; Helena Rey Acuña; M Manuela Fontanillo Fontanillo
Journal:  J Extra Corpor Technol       Date:  2013-12

2.  Mimicking the Endothelium: Dual Action Heparinized Nitric Oxide Releasing Surface.

Authors:  Ryan Devine; Marcus J Goudie; Priyadarshini Singha; Chad Schmiedt; Megan Douglass; Elizabeth J Brisbois; Hitesh Handa
Journal:  ACS Appl Mater Interfaces       Date:  2020-04-22       Impact factor: 9.229

3.  Local and systemic application of tranexamic acid in heart valve surgery: a prospective, randomized, double blind LOST study.

Authors:  Jan Spegar; Tomas Vanek; Jana Snircova; Richard Fajt; Zbynek Straka; Petra Pazderkova; Marek Maly
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

4.  First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of action.

Authors:  Pierre Gueret; S Combe; C Krezel; E Fuseau; P L M van Giersbergen; M Petitou; E Neuhart
Journal:  Eur J Clin Pharmacol       Date:  2016-06-03       Impact factor: 2.953

5.  A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling.

Authors:  Daniel C Leslie; Anna Waterhouse; Julia B Berthet; Thomas M Valentin; Alexander L Watters; Abhishek Jain; Philseok Kim; Benjamin D Hatton; Arthur Nedder; Kathryn Donovan; Elana H Super; Caitlin Howell; Christopher P Johnson; Thy L Vu; Dana E Bolgen; Sami Rifai; Anne R Hansen; Michael Aizenberg; Michael Super; Joanna Aizenberg; Donald E Ingber
Journal:  Nat Biotechnol       Date:  2014-10-12       Impact factor: 54.908

6.  Massive atrial myxoma requiring emergency cardiopulmonary bypass in a patient with heparin resistance.

Authors:  E Houston; P Moran; D Mayhew
Journal:  Anaesth Rep       Date:  2020-08-09

7.  Major themes for 2010 in cardiothoracic and vascular anesthesia.

Authors:  H Riha; J Fassl; P Patel; T Wyckoff; J Choi; J G Augoustides
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2011

Review 8.  Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays.

Authors:  Jonathan Douxfils; Anne Tamigniau; Bernard Chatelain; Catherine Goffinet; Jean-Michel Dogné; François Mullier
Journal:  Thromb J       Date:  2014-11-04

9.  Anticoagulation Management and Heparin Resistance During Cardiopulmonary Bypass: A Survey of Society of Cardiovascular Anesthesiologists Members.

Authors:  Roman M Sniecinski; Elliott Bennett-Guerrero; Linda Shore-Lesserson
Journal:  Anesth Analg       Date:  2019-08       Impact factor: 5.108

10.  Heparin dose calculated according to lean body weight during on-pump heart surgery.

Authors:  Aslıhan Aykut; Ülkü Sabuncu; Zeliha Aslı Demir; Eda Balcı; Başak Soran Türkcan; Utku Ünal; Ayşegül Özgök
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-09-16       Impact factor: 0.332
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.